Stallion India Fluorochemicals Ltd Share Price – NSE  / BSE

Chemicals, Small Cap

Stallion India Fluorochemicals has received environmental clearance from the State Environment Impact Assessment Aulhomy (SEIAA), Rajasthan, for proposed R-32 obtained manufacturing plant with an approved capacity of 10,000 MT per annum, generation of Hydrochloric Acid (HCI - 30%) as a by-product with a capacity of 46,460 MT per annum, and manufacture of non-EC blended refrigerants including R-410A, R-407C, R- 404A, R-507A, R-454B, R-513A, R-515B, R-449A and R-448A with an aggregate capacity of 7,500 MT per annum, at Plot No. SP3-10, RIICO Industrial Area, Ukhaliya, Tehsil - Hurda, District - Bhilwara, Rajasthan.

Powered by Capital Market - Live News

In a press release, the company said the promoter sold 16,20,987 shares worth Rs 45.74 crore and will infuse the entire amount back into the company on an interest-free basis. The funds are intended to ensure timely commencement of groundwork and construction for the upcoming R-32 facility.

The company clarified that the infusion would be made without any equity dilution.

Managing director and CEO Shazad Rustomji said the move demonstrates his personal commitment to advancing the company's self-reliance goals in the fluorochemicals manufacturing segment. This infusion ensures work on our R-32 project begins without delay, while maintaining our capital structure, he noted.

Stallion India Fluorochemicals is a specialized leader in the refrigerants and industrial gases sector. It is engaged in processing, blending, and distributing gases across diverse industries including air conditioning, refrigeration, fire-fighting, semiconductor manufacturing, pharmaceuticals, automotive, and glass production. The company operates four strategic manufacturing facilities located in Khalapur, Ghiloth, Manesar, and Panvel, specializing in the debulking, blending, and processing of gases.

The company reported a net profit of Rs 11.41 crore in Q2 FY26, a sharp rise from Rs 0.85 crore in Q2 FY25. Revenue grew 56.3% year-on-year to Rs 105.56 crore, while EBITDA surged to Rs 15.77 crore from Rs 2.35 crore a year ago. Profit before tax stood at Rs 15.24 crore, compared with Rs 0.55 crore in the same quarter last year.

The stock debuted on the bourses on 23 January 2025, listing at Rs 120, a premium of 33.33% over the issue price of Rs 90. The initial public offer (IPO) of Stallion India Fluorochemicals was subscribed 188.38 times. The issue was open for bidding from 16 to 20 January 2025, with a price band fixed between Rs 85 and Rs 90 per share.

The stock hit a record high of Rs 424.20 on 17 October 2025. Since then, it has been on a downward spiral, declining 41.62% to the current level.

Powered by Capital Market - Live News

The stock has tumbled 22.6% in five consecutive sessions. The stock is up 32.74% in one month and 40.19% in three months.

The company announced today, 24 October 2025, that it has begun groundwork on its upcoming 10,000 MT R-32 manufacturing facility in Bhilwara, Rajasthan, following the completion of its Bhoomi Pooja ceremony on 19 October 2025. The company has finalized all contracting and technology transfer agreements, with construction set to start on 1 November 2025.

Managing director and CEO Shazad Rustomji said the Rs 200 crore project marks a key step toward Stallion India's goal of becoming a fully integrated fluorochemicals enterprise. Scheduled for commissioning by July 2026, the plant is expected to generate around Rs 500 crore in revenue with PAT margins of 22-24%, strengthening the company?s growth and self-reliance in refrigerant manufacturing.

Stallion India Fluorochemicals is a leading player in the refrigerants and industrial gases sector. The company operates four manufacturing facilities at Khalapur, Ghiloth, Manesar, and Panvel, specializing in the debulking, blending, and processing of gases. Unlike traditional producers of base molecules, Stallion India focuses on custom gas blending, catering to industries such as air conditioning, refrigeration, fire safety, semiconductors, pharmaceuticals, automotive, and glass manufacturing. Its product range includes Hydrocarbons (HCs), Hydrofluorocarbons (HFCs), and Hydrofluoroolefins (HFOs).

The company reported a net profit of Rs 11.41 crore in Q2 FY26, a sharp rise from Rs 0.85 crore in Q2 FY25. Revenue grew 56.3% year-on-year to Rs 105.56 crore, while EBITDA surged to Rs 15.77 crore from Rs 2.35 crore a year ago. Profit before tax stood at Rs 15.24 crore, compared with Rs 0.55 crore in the same quarter last year.

The stock was listed on 23 January 2025 at Rs 120, a 33.33% premium to its issue price of Rs 90. The initial public offer (IPO) of Stallion India Fluorochemicals was subscribed 188.38 times. The issue was open for bidding from 16 to 20 January 2025, with a price band of Rs 85-90 per share.

Powered by Capital Market - Live News

Revenues increased by 56.3% year-over-year (YoY) to Rs 105.56 crore during the quarter.

Total expenditure rose by 37.1% to Rs 89.98 crore in Q2 FY26 over Q2 FY25, primarily due to a sharp increase in raw material costs (up 71% YoY) and higher employee expenses (up 5.8x YoY).

EBITDA jumped to Rs 15.77 crore in Q2 FY26 from Rs 2.35 crore in Q2 FY25.

Profit before tax in Q2 FY26 stood at Rs 15.24 crore, which is sharply higher from Rs 0.55 crore posted in Q2 FY26.

Shazad Rustomji, managing director & CEO of Stallion India Fluorochemicals, said: ?The company delivered a strong performance during Q2 and H1 FY25-26, marked by significant growth in revenue and profitability.

Total revenue for H1 FY25-26 increased by 52.8% YoY to Rs 216.30 crore, while PAT rose sharply by 135.0% to Rs 21.78 crore. The improvement was driven by higher volumes, better product mix, and operational efficiencies across key facilities, reflecting the company?s strong execution and resilient business model.

During FY 2025-26, the Company has navigated a challenging business environment characterized by cyclical slowdown, political and tariff-related headwinds, and global macroeconomic uncertainties. Notwithstanding these factors, the management had provided a revenue guidance of Rs 430 crore for FY 2025-26.?

Stallion India Fluorochemicals operates in the refrigerants and industrial gases sector. The company is engaged in processing, blending, and distributing gases across diverse industries including air conditioning, refrigeration, fire-fighting, semiconductor manufacturing, pharmaceuticals, automotive, and glass production.

Powered by Capital Market - Live News